Which countries run stem-cell trials for Heart Failure & Cardiac Repair?
32 countries host at least one registered site; United States alone accounts for around 38% of mentions in this snapshot (2026-08-29).
Country distribution
| Country | Studies with a site there |
|---|---|
| United States | 36 |
| China | 12 |
| Denmark | 8 |
| Slovenia | 7 |
| Canada | 6 |
| Germany | 6 |
| Netherlands | 5 |
| Italy | 5 |
| Japan | 5 |
| Spain | 5 |
A study with sites in several countries is counted once per country, taken from the location block of each registry record.
What the map means for Heart Failure & Cardiac Repair
Cardiac cell studies concentrate in centres with catheterisation labs and imaging cores, since delivery is often intracoronary or intramyocardial. Intravenous infusion in a day clinic is a different intervention from what most registered cardiac trials tested.
Where recruitment is actually open
| Country | Open studies with a site there |
|---|---|
| United States | 4 |
| China | 2 |
| Slovenia | 2 |
| Australia | 1 |
| Austria | 1 |
| Belgium | 1 |
| Canada | 1 |
| France | 1 |
What travelling for a trial actually involves
Cross-border participation fails on logistics more often than on eligibility: follow-up schedules, local insurance, visa duration and who pays for complications. A site that cannot answer those in writing is not going to enrol you.
Multi-country studies, named
Registered studies with sites in more than one country — the clearest evidence of collaboration rather than a single-centre series.
- NCT03394365 — A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative (Australia, Austria, Belgium, Canada, France, Italy)
Why trial geography is not a shortlist
The map is drawn by policy and money. Permissive or well-defined regulatory pathways attract registrations and large research budgets attract more still. None of that transfers to the private clinic advertising in the same city, which may operate under no comparable supervision.
Before treating geography as a shortlist, read the legality overview by country and what "best country" actually means here.
When these studies started
Registrations by start year since 2020: 2020 (6), 2021 (6), 2022 (6), 2023 (4), 2025 (5), 2026 (6). Activity for this condition spans 2002 to 2026, which shows whether interest is growing, flat or past its peak.
Frequently asked
Which countries run stem-cell trials for Heart Failure & Cardiac Repair?
Sites are registered in 32 countries; the largest is United States (~38% of country mentions, 2026-08-29).
Does a country with many trials mean better treatment there?
It does not follow. A country can host many trials and still have an unregulated commercial sector selling something quite different to visitors.
Are trial sites and commercial clinics the same thing?
Rarely. Academic trial sites and the private clinics advertising to medical tourists are typically separate organisations with different oversight.
Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.
More on this condition
- Heart Failure & Cardiac Repair: cell-therapy evidence and registered trials
- How much does stem cell therapy for Heart Failure & Cardiac Repair cost? (2026)
- Heart Failure & Cardiac Repair stem cell therapy — your questions answered (2026)
- Heart Failure & Cardiac Repair: cell-therapy evidence by therapy class
- MSC vs HSCT for Heart Failure & Cardiac Repair: what the registries show